Author:
Erten N.,Saka B.,Berberoglu K.,Turkmen C.,Unal S.,Bakir B.,Yekeler E.,Besisik S. K.
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference19 articles.
1. Ak I, Aslan V, Vardareli E, Gulbas Z (2003) Tc-99m methoxy isobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells. Ann Hematol 82:88–92
2. Alexandrakis MG, Kyriakou DS, Passam FH, Malliaraki N, Christophoridou AV, Karkavitsas N (2002) Correlation between the uptake of Tc-99m-sestaMIBI and prognostic factors in patients with multiple myeloma. Clin Lab Haematol 24:155–159
3. Attal M, Harousseau JL, Stoppa AM, Sotta JJ, Fuzibet JG, Rossi JF, Cassassus P, Maissonneuve H, Facon T, Ifrah N, Payen C, Bataille R (1996) A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335:91–97
4. Bacovsky J, Scudla V, Myslivecek M, Nekula J, Vytrasova M (2005) Scintigraphy using (99 m)Tc-MIBI (sestamibi), a sensitive parameter of activity of multiple myeloma. Neoplasma 52:302–306
5. Baur-Melnyk A, Buhmann S, Durr HR, Reiser M (2005) Role of MRI for the diagnosis and prognosis of multiple myeloma. Eur J Radiol 55:56–63
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献